Tuesday Plenary
Plenary Session
ORGANIZERS: Nivedita Agarwal, Karin Markenroth Bloch
Tuesday, 07 May 2024
Plenary Hall (Hall 603-604)
10:30 -
12:00
Moderators: Nivedita Agarwal & Karin Markenroth Bloch
Session Number: P-02
CME and CE Credit
Session Number: P-02
Overview
mTBI affects millions of people world-wide and causes long-term physical and cognitive disability. mTBI is a complex neurological disease with several neuropathological processes including neuroinflammation, altered brain drainage systems and progression to neurodegeneration. Conventional MR imaging is not sensitive to subtle brain alterations or white matter disruptions, and findings represent the “tip of the iceberg”. In this plenary, we draw attention to this debilitating disease, the urgent need to find clinically relevant MR biomarkers and implement advanced MR techniques that will benefit patients with mTBI.
Target Audience
All members at any stage of career or area of expertise will benefit from this plenary that describes the extent of burden and the devastating consequences of mTBI. mTBI is underdiagnosed and still lacks a MR biomarker making it hard to diagnose the extent of clinical damage and prognosis.
Educational Objectives
As a result of attending this course, participants should be able to:
- Describe causes and clinical symptoms of mild traumatic brain injuries (mTBI);
- Compare MRI methods used for mTBI research in preclinical models and clinical cohorts; and
- Discuss how novel MRI techniques could benefit the diagnosis and treatment follow-up of mTBI.
| 10:30 | | NIBIB New Horizons Lecture: Random Walks Toward an In Vivo MR Microscope Ileana Jelescu |
| 11:00 | | Introduction |
| 11:05 | | The Fallacy of Mild Traumatic Brain Injury Yvonne Lui |
| 11:30 | | Imaging Preclinical Models of mTBI David Wright |
| 11:55 | | Closing Remarks |